Jobs

Discover opportunities across our network
Camford Capital
Camford Capital
22
companies
164
Jobs
Powered by Getro
Showing 22 companies
Ceribell
Ceribell
53 jobs
Biotechnology
DeepTech
Health
201 - 1000
Series C+

Ceribell focuses on making electroencephalography (EEG) widely accessible, more efficient, and more cost-effective. The company creates and validates an FDA cleared instant EEG system that does not require an EEG technologist or specialist interpreter, which allows for faster results and clinical decision making. The Ceribell EEG System can be set up by any healthcare provider in 6 minutes and offers a proprietary Brain Stethoscope function that dramatically simplifies interpretation of EEG results by converting brainwaves to sound so seizures can be detected by listening. Earlier diagnosis and focused treatment for patients with seizures, including non-convulsive seizures that can only be diagnosed with EEG, can significantly lower mortality, secondary brain injury, length of stay, and risk of complications.

Biotechnology
DeepTech
Health
201 - 1000

Beam Therapeutics is a biotechnology company engaged in creating genetic medicines based on its base editing technology. Beam is pioneering the use of base editing, a potential new class of precision genetic medicines, with a vision of providing life-long cures to patients suffering from serious diseases. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing.

CertiK
CertiK
21 jobs
Blockchain and Crypto
Security
Software
201 - 1000
Series B

CertiK is a pioneer in blockchain security, leveraging best-in-class AI technology to protect and monitor blockchain protocols and smart contracts. Founded in 2018 by professors from Yale University and Columbia University, CertiK’s mission is to secure the web3 world. CertiK applies cutting-edge innovations from academia to enterprise, enabling mission-critical applications to scale with safety and correctness.

PathAI
PathAI
15 jobs
Biotechnology
DeepTech
Health
201 - 1000

PathAI’s services solve challenging pathology problems faced by the research and pharmaceutical industry. The PathAI platform provides end-to-end automation for reliable, scalable, and cost-effective long-term solutions. PathAI is developing technology that assists pathologists in making rapid and accurate diagnoses for every patient, every time. The company was founded in 2016 and based in Boston, Massachusetts.

Biotechnology
DeepTech
Health
51 - 200
Series C+

CG Oncology formerly known as Cold Genesys is a privately held, clinical-stage biopharmaceutical company that focuses on the research, acquisition, and development of novel immunotherapies. It specializes in the development of oncolytic immunotherapies to combat cancer, providing patients with new and impactful therapies. CG Oncology acquired the rights to develop CG0070 from BioSante Pharmaceuticals (Nasdaq: BPAX). A phase I/IIa dose-escalating clinical trial has already been completed in 35 patients with NMIBC. Cold Genesys is hopeful to get this therapy back into the clinical setting with the initiation of the proposed phase II/III trial.

Viz
Viz
8 jobs
Data and Analytics
DeepTech
Health
Software
201 - 1000

Viz helps physicians to identify anomalies in brain scans through machine learning. The company leverages advanced deep learning to communicate time-sensitive information about stroke patients straight to a specialist who can intervene and treat. It uses deep learning algorithms to identify a suspected large vessel occlusion, a particularly disabling type of stroke, in a CT scan and alerts the stroke team specialist within minutes. Viz has developed deep learning algorithms to analyze brain scans for large vessel occlusions (LVOs), a disabling type of stroke. The company also allows the stroke center’s clinicians to rapidly share images back and forth. Viz's mission is to fundamentally improve how healthcare is delivered in the world, through intelligent software that promises to reduce time to treatment and improve access to care. Viz was founded in 2016 and is based in San Francisco, California.

InfStones
InfStones
7 jobs
Blockchain and Crypto
Hardware
Internet Services
11 - 50
Series C+

Founded in 2018 with offices across three countries and two continents, InfStones is the world's leading blockchain infrastructure provider. Currently, InfStones provides services to large institutional clients around the globe, supporting thousands of nodes on more than 50 public blockchains through its universal platform.

SFOX
SFOX
5 jobs
Blockchain and Crypto
Finance
Lending and Investments
Software
51 - 200
Series A

SFOX is a cryptocurrency prime dealer that provides professional traders and institutional investors higher returns when trading large volumes, through smart routing and a global integrated order book.

DFINITY
DFINITY
4 jobs
Blockchain and Crypto
Finance
Internet Services
Software
201 - 1000

The DFINITY Foundation’s mission is to build, promote, and maintain the Internet Computer — the world’s first web-speed, internet-scale public blockchain. It enables smart contracts to securely serve interactive web content directly into the browsers of end users, making it possible to build dapps, DeFi, open internet services, and enterprise systems that are capable of operating at hyperscale. The Internet Computer uses smart contracts to power an emerging decentralized ecosystem of interoperable dapps and services, where nearly every system and service can run in reimagined form on public blockchain.

Biotechnology
Data and Analytics
DeepTech
Health
Software
11 - 50
Series A

Engine Biosciences is a biotech company that applies machine learning to genomics for drug discovery. Engine Biosciences is a venture-backed San Francisco- and Asia-based technology company pioneering network biomedicine. The company's proprietary and patented technologies oriented around deciphering the complexity of biology networks include both high-throughput wet lab experimentation and artificial intelligence algorithms for drug discovery and cellular reprogramming. This platform, developed through several years of research by our scientific founding and leadership team who include faculty members at MIT, Harvard, Mayo Clinic, and UCSD, dramatically accelerates and reduces costs of the R&D process for new medical therapies. We are actively applying the platform internally and with partners across a range of disease indications.

Data and Analytics
DeepTech
Health
Software
11 - 50

iSono Health is transforming breast cancer screening by combining automated ultrasound and artificial intelligence (AI) to empower women and physicians with accessible and personalized breast health monitoring.

Biotechnology
DeepTech
Health
11 - 50
Series A

Totus Medicines uses revolutionary chemical biology to create life-changing therapies to treat previously untreatable diseases across the entire human genome.